Home Studieinformatie Studies in voorbereiding

Acute myeloïde leukemie (AML)

NK4AML: Infusion of ex vivo-generated allogeneic natural killer cells in combination with subcutaneous IL-2 in patients with acute myeloid leukemia: a phase I/IIa study

Myelodysplastisch syndroom (MDS)

IMerge 2: A study to evaluate imetelstat (GRN163L) in transfusion-dependent subjects with IPSS low or intermediate-1 risk myelodysplastic syndrome (MDS) that is relapsed/refractory to erythropoiesis-stimulating agent (ESA) treatment

Supportive care

REDDS2: A randomised feasibility n-of-1 trial of weekly-interval red cell transfusion in myelodysplastic syndrome

DUET2: Azole-echinocandin combination therapy for invasive aspergillosis. A randomized pragmatic superiority trial

ReSPECT: A phase 3, multicenter, randomized, double-blind study of the efficacy and safety of rezafungin for injection versus the standard antimicrobial regimen to prevent invasive fungal diseases in adults undergoing allogeneic blood and marrow transplantation

Stolling

TAP-100: Validation TAP-100 blood collection device

HISTORY: Hypoplasminogenemia: an international retrospective and prospective cohort study

OPTI-CLOT: To WiN: Implementation of pharmacokinetic-guided dosing of DDAVP and VWF-containing concentrates in von Willebrand disease

Hemoglobinopathie

SCORE: Sickle cell outcome research

Sickle cell screen: Investigating red blood cell deformability of sickle cell patients before and after the start of therapy


Ga terug naar de algemene homepage Studieprotocollen.